Design, synthesis and pharmacological activity of novel enantiomerically pure phosphonic acid-based NAALADase inhibitors
- 1 January 2007
- journal article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 5 (5) , 826-831
- https://doi.org/10.1039/b615603g
Abstract
Inhibitors of NAALADase have shown promise for a variety of diseases associated with glutamate excitotoxicity, and could be useful for the diagnosis and therapy of prostate cancer. A series of novel enantiomerically pure 2-(phosphonomethyl)pentanedioic acid (2-PMPA) based NAALADase inhibitors were synthesized. These compounds were prepared from previously reported (S)-2-(hydroxyphosphinoylmethyl)pentanedioic acid benzyl ester 4. Biological test results showed that the new compounds are good to outstanding NAALADase inhibitors. Compounds 8b and 10b showed activity similar to the known potent inhibitor (S)-2-PMPA. Fluorescently labeled inhibitor 19b may potentially be used to study binding to prostate cancer cells by fluorescence microscopy, and siderophore-containing inhibitor 21b may be useful for detection of prostate-derived cancer cells by magnetic resonance imaging (MRI).Keywords
This publication has 27 references indexed in Scilit:
- Prostate specific membrane antigen (PSMA) expression gives prostate cancer cells a growth advantage in a physiologically relevant folate environment in vitroThe Prostate, 2006
- NAAG peptidase inhibitors and their potential for diagnosis and therapyNature Reviews Drug Discovery, 2005
- Targeted therapies for prostate cancerEmerging Therapeutic Targets, 2005
- Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic AgentsJournal of Medicinal Chemistry, 2004
- Prostate targeting ligands based on N-acetylated α-linked acidic dipeptidaseBiochemical and Biophysical Research Communications, 2003
- Glutamate Carboxypeptidase II Inhibition as a Novel Therapeutic TargetPublished by Springer Nature ,2002
- Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)Journal of Medicinal Chemistry, 2001
- Characterization of the enzymatic activity of PSM: Comparison with brain NAALADaseThe Prostate, 1999
- Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.Proceedings of the National Academy of Sciences, 1996
- Design, Synthesis, and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated α-Linked Acidic DipeptidaseJournal of Medicinal Chemistry, 1996